Data from TCGA database analyses also revealed that approximately 50% of colon cancer patients had elevated ACAD9 mRNA levels, while the majority of patients displayed a reduction in ACADS mRNA (Fig. 6f). The gene discussed is ACAD9; the disease is malignant colon neoplasm.